Structured evidence table for Hydroxytyrosol Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Hydroxytyrosol Blood Pressure Randomized Trial | More recently, the focus has shifted to how eating habits can influence and reduce vascular risk. | 4 | Pacinella Gaetano (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health—Narrative Review |
| Hydroxytyrosol Blood Pressure Randomized Trial | The purpose of this article is to compile and present recent findings on how the MedDiet can lower cerebrovascular risk, while highlighting the pressing need to incorporate nutritional strategies into both medical practice and public health initiatives aimed at preventing vascular diseases. | 4 | Pacinella Gaetano (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health—Narrative Review |
| Hydroxytyrosol Blood Pressure Randomized Trial | 7 Most strokes are ischemic and can be traced to changeable lifestyle and metabolic risk factors. | 4 | Pacinella Gaetano (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health—Narrative Review |
| Hydroxytyrosol Blood Pressure Randomized Trial | 1 Cerebrovascular disorders, particularly those with ischemic pathogenesis such as ischemic stroke due to vascular occlusion or small vessel disease, continue to be a major contributor to death and lasting disability across the globe, largely fueled by modifiable factors like high blood pressure, dyslipidemia, excess weight, and chronic inflammation. | 4 | Pacinella Gaetano (2026) | The Mediterranean Diet and Cerebrovascular Risk Factors: A Lifeline for Vascular Health—Narrative Review |
| Hydroxytyrosol Blood Pressure Randomized Trial | Methods This randomized, single-masked (investigator and data analysis) interventional pilot study protocol will enroll 156 high-risk pregnant women (8 to 16 weeks of gestation) at Barzilai University Medical Center. | 4 | Ovadia YS (2026) | An interventional pilot study protocol on the effect of extra virgin olive oil on women with preeclampsia risk. |
| Hydroxytyrosol Blood Pressure Randomized Trial | Discussion This pilot study will provide crucial insights into the potential of EVOOEH as a dietary intervention for reducing PE risk in high-risk pregnancies, addressing a significant gap in current preventive strategies. | 4 | Ovadia YS (2026) | An interventional pilot study protocol on the effect of extra virgin olive oil on women with preeclampsia risk. |
| Hydroxytyrosol Blood Pressure Randomized Trial | This protocol study findings can inform larger-scale trials and contribute to evidence-based nutritional recommendations for PE prevention. | 4 | Ovadia YS (2026) | An interventional pilot study protocol on the effect of extra virgin olive oil on women with preeclampsia risk. |
| Hydroxytyrosol Blood Pressure Randomized Trial | Background Preeclampsia (PE), a multisystem and complex disorder diagnosed when maternal hypertension manifests after 20 weeks of gestation with proteinuria, is one of the direct causes of maternal morbidity and mortality, in addition to bleeding and infection. | 4 | Ovadia YS (2026) | An interventional pilot study protocol on the effect of extra virgin olive oil on women with preeclampsia risk. |
Source documents